Invasive Species Compendium

Detailed coverage of invasive species threatening livelihoods and the environment worldwide

Datasheet

Mycoplasma mycoides subsp. mycoides small colony (SC) type

Toolbox

Datasheet

Mycoplasma mycoides subsp. mycoides small colony (SC) type

Summary

  • Last modified
  • 27 July 2017
  • Datasheet Type(s)
  • Invasive Species
  • Preferred Scientific Name
  • Mycoplasma mycoides subsp. mycoides small colony (SC) type
  • Taxonomic Tree
  • Domain: Bacteria
  •   Phylum: Firmicutes
  •     Class: Mollicutes
  •       Order: Mycoplasmatales
  •         Family: Mycoplasmataceae

Don't need the entire report?

Generate a print friendly version containing only the sections you need.

Generate report

Pictures

Top of page
PictureTitleCaptionCopyright
M. m. mycoides SC colonies after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
TitleCBPP Diagnostic Media
CaptionM. m. mycoides SC colonies after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
CopyrightJohn B. Bashiruddin
M. m. mycoides SC colonies after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
CBPP Diagnostic MediaM. m. mycoides SC colonies after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.John B. Bashiruddin
Single M. m. mycoides SC colony after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
TitleCBPP Diagnostic Media
CaptionSingle M. m. mycoides SC colony after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
CopyrightJohn B. Bashiruddin
Single M. m. mycoides SC colony after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.
CBPP Diagnostic MediaSingle M. m. mycoides SC colony after 7 days of incubation on CBPP Diagnostic Media showing dark pigmentation and red crystalline deposits.John B. Bashiruddin
Immunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune serum against M. m. mycoides SC. Distended zone of cellular infiltration in a nectrotic area with concentrated staining, (original x20). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
TitleHistology
CaptionImmunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune serum against M. m. mycoides SC. Distended zone of cellular infiltration in a nectrotic area with concentrated staining, (original x20). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
CopyrightJohn B. Bashiruddin
Immunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune serum against M. m. mycoides SC. Distended zone of cellular infiltration in a nectrotic area with concentrated staining, (original x20). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
HistologyImmunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune serum against M. m. mycoides SC. Distended zone of cellular infiltration in a nectrotic area with concentrated staining, (original x20). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.John B. Bashiruddin
Immunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune srum against M. m. mycoides SC. Positive specific reactivity surrounding a small blood vessel with a perrivascular 'cuff' of lymphocyte infiltration and endothilial damage (original x40). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
TitleHistology
CaptionImmunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune srum against M. m. mycoides SC. Positive specific reactivity surrounding a small blood vessel with a perrivascular 'cuff' of lymphocyte infiltration and endothilial damage (original x40). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
CopyrightJohn B. Bashiruddin
Immunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune srum against M. m. mycoides SC. Positive specific reactivity surrounding a small blood vessel with a perrivascular 'cuff' of lymphocyte infiltration and endothilial damage (original x40). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.
HistologyImmunohistochemical staining of sections on CBPP-affected lung with the peroxidase-anti-peroxidase (PAP) method and rabbit hyperimmune srum against M. m. mycoides SC. Positive specific reactivity surrounding a small blood vessel with a perrivascular 'cuff' of lymphocyte infiltration and endothilial damage (original x40). Brown colour indicates areas of stain deposition indicative of the presence of mycoplasma antigen.John B. Bashiruddin

Identity

Top of page

Preferred Scientific Name

  • Mycoplasma mycoides subsp. mycoides small colony (SC) type Freundt, 1955

Other Scientific Names

  • Mycoplasma mycoides mycoides SC
  • Mycoplasma mycoides subsp. mycoides SC
  • Mycoplasma mycoides subspecies mycoides SC

English acronym

  • MmmSC

Taxonomic Tree

Top of page
  • Domain: Bacteria
  •     Phylum: Firmicutes
  •         Class: Mollicutes
  •             Order: Mycoplasmatales
  •                 Family: Mycoplasmataceae
  •                     Genus: Mycoplasma
  •                         Species: Mycoplasma mycoides subsp. mycoides small colony (SC) type

Distribution Table

Top of page

The distribution in this summary table is based on all the information available. When several references are cited, they may give conflicting information on the status. Further details may be available for individual references in the Distribution Table Details section which can be selected by going to Generate Report.

Continent/Country/RegionDistributionLast ReportedOriginFirst ReportedInvasiveReferenceNotes

Asia

AfghanistanDisease not reportedOIE Handistatus, 2005
AzerbaijanDisease never reportedOIE Handistatus, 2005
BahrainDisease never reportedOIE Handistatus, 2005
BangladeshDisease not reportedOIE Handistatus, 2005
BhutanNo information availableOIE Handistatus, 2005
Brunei DarussalamDisease not reportedOIE Handistatus, 2005
China
-Hong KongDisease never reportedOIE Handistatus, 2005
Georgia (Republic of)Last reported1932OIE Handistatus, 2005
IndiaLast reported1990OIE Handistatus, 2005
IndonesiaDisease never reportedOIE Handistatus, 2005
IranDisease never reportedOIE Handistatus, 2005
IraqDisease never reportedOIE Handistatus, 2005
IsraelNo information availableOIE Handistatus, 2005
JapanLast reported1941OIE Handistatus, 2005
JordanDisease never reportedOIE Handistatus, 2005
KazakhstanDisease not reportedOIE Handistatus, 2005
Korea, DPRDisease not reportedOIE Handistatus, 2005
Korea, Republic ofDisease never reportedOIE Handistatus, 2005
KuwaitLast reported1991OIE Handistatus, 2005
LebanonDisease not reportedOIE Handistatus, 2005
Malaysia
-Peninsular MalaysiaDisease never reportedOIE Handistatus, 2005
-SabahDisease never reportedOIE Handistatus, 2005
-SarawakDisease never reportedOIE Handistatus, 2005
MongoliaLast reported1973OIE Handistatus, 2005
MyanmarLast reported1995OIE Handistatus, 2005
NepalDisease not reportedOIE Handistatus, 2005
OmanDisease never reportedOIE Handistatus, 2005
PhilippinesDisease never reportedOIE Handistatus, 2005
QatarLast reported1997OIE Handistatus, 2005
Saudi ArabiaDisease not reportedOIE Handistatus, 2005
SingaporeDisease never reportedOIE Handistatus, 2005
Sri LankaDisease never reportedOIE Handistatus, 2005
SyriaDisease not reportedOIE Handistatus, 2005
TaiwanDisease never reportedOIE Handistatus, 2005
TajikistanDisease never reportedOIE Handistatus, 2005
ThailandDisease never reportedOIE Handistatus, 2005
TurkeyDisease never reportedOIE Handistatus, 2005
TurkmenistanDisease never reportedOIE Handistatus, 2005
United Arab EmiratesLast reported1990OIE Handistatus, 2005
UzbekistanDisease never reportedOIE Handistatus, 2005
VietnamDisease never reportedOIE Handistatus, 2005
YemenNo information availableOIE Handistatus, 2005

Africa

AlgeriaDisease never reportedOIE Handistatus, 2005
AngolaReported present or known to be presentOIE Handistatus, 2005
BeninReported present or known to be presentOIE Handistatus, 2005
BotswanaLast reported1995OIE Handistatus, 2005
Burkina FasoReported present or known to be presentOIE Handistatus, 2005
BurundiDisease not reportedOIE Handistatus, 2005
CameroonOIE Handistatus, 2005
Cape VerdeDisease never reportedOIE Handistatus, 2005
Central African RepublicDisease not reportedOIE Handistatus, 2005
ChadReported present or known to be presentOIE Handistatus, 2005
Congo Democratic RepublicReported present or known to be presentOIE Handistatus, 2005
Côte d'IvoireReported present or known to be presentOIE Handistatus, 2005
DjiboutiCAB Abstracts data miningOIE Handistatus, 2005
EgyptLast reported1971OIE Handistatus, 2005
EritreaLast reported2003OIE Handistatus, 2005
EthiopiaReported present or known to be presentOIE Handistatus, 2005
GhanaReported present or known to be presentOIE Handistatus, 2005
GuineaOIE Handistatus, 2005
Guinea-BissauDisease not reportedOIE Handistatus, 2005
KenyaReported present or known to be presentOIE Handistatus, 2005
LibyaDisease never reportedOIE Handistatus, 2005
MadagascarDisease never reportedOIE Handistatus, 2005
MalawiDisease never reportedOIE Handistatus, 2005
MaliReported present or known to be presentOIE Handistatus, 2005
MauritiusDisease never reportedOIE Handistatus, 2005
MoroccoDisease never reportedOIE Handistatus, 2005
MozambiqueDisease never reportedOIE Handistatus, 2005
NamibiaOIE Handistatus, 2005
NigerReported present or known to be presentOIE Handistatus, 2005
NigeriaReported present or known to be presentOIE Handistatus, 2005
RéunionDisease never reportedOIE Handistatus, 2005
RwandaNo information availableOIE Handistatus, 2005
Sao Tome and PrincipeDisease not reportedOIE Handistatus, 2005
SenegalLast reported1977OIE Handistatus, 2005
SeychellesDisease not reportedOIE Handistatus, 2005
SomaliaNo information availableOIE Handistatus, 2005
South AfricaLast reported1924OIE Handistatus, 2005
SudanReported present or known to be presentOIE Handistatus, 2005
SwazilandDisease never reportedOIE Handistatus, 2005
TanzaniaReported present or known to be presentOIE Handistatus, 2005
TogoReported present or known to be presentOIE Handistatus, 2005
TunisiaDisease never reportedOIE Handistatus, 2005
UgandaReported present or known to be presentOIE Handistatus, 2005
ZambiaReported present or known to be presentOIE Handistatus, 2005
ZimbabweLast reported1904OIE Handistatus, 2005

North America

BermudaDisease not reportedOIE Handistatus, 2005
CanadaLast reported1876OIE Handistatus, 2005
MexicoDisease never reportedOIE Handistatus, 2005
USALast reported1892OIE Handistatus, 2005

Central America and Caribbean

BarbadosDisease never reportedOIE Handistatus, 2005
BelizeDisease never reportedOIE Handistatus, 2005
British Virgin IslandsDisease never reportedOIE Handistatus, 2005
Cayman IslandsDisease never reportedOIE Handistatus, 2005
Costa RicaDisease never reportedOIE Handistatus, 2005
CubaDisease never reportedOIE Handistatus, 2005
CuraçaoDisease not reportedOIE Handistatus, 2005
DominicaDisease not reportedOIE Handistatus, 2005
Dominican RepublicDisease never reportedOIE Handistatus, 2005
El SalvadorDisease never reportedOIE Handistatus, 2005
GuadeloupeDisease never reportedOIE Handistatus, 2005
GuatemalaDisease never reportedOIE Handistatus, 2005
HaitiDisease never reportedOIE Handistatus, 2005
HondurasDisease never reportedOIE Handistatus, 2005
JamaicaDisease never reportedOIE Handistatus, 2005
MartiniqueDisease not reportedOIE Handistatus, 2005
NicaraguaDisease never reportedOIE Handistatus, 2005
PanamaDisease never reportedOIE Handistatus, 2005
Saint Kitts and NevisDisease never reportedOIE Handistatus, 2005
Saint Vincent and the GrenadinesDisease never reportedOIE Handistatus, 2005
Trinidad and TobagoDisease never reportedOIE Handistatus, 2005

South America

ArgentinaDisease never reportedOIE Handistatus, 2005
BoliviaDisease never reportedOIE Handistatus, 2005
BrazilDisease never reportedOIE Handistatus, 2005
ChileDisease never reportedOIE Handistatus, 2005
ColombiaDisease never reportedOIE Handistatus, 2005
EcuadorDisease never reportedOIE Handistatus, 2005
Falkland IslandsDisease never reportedOIE Handistatus, 2005
French GuianaDisease not reportedOIE Handistatus, 2005
GuyanaDisease never reportedOIE Handistatus, 2005
ParaguayDisease never reportedOIE Handistatus, 2005
PeruDisease never reportedOIE Handistatus, 2005
UruguayDisease never reportedOIE Handistatus, 2005
VenezuelaDisease never reportedOIE Handistatus, 2005

Europe

AndorraLast reported1957OIE Handistatus, 2005
AustriaLast reported1921OIE Handistatus, 2005
BelarusDisease never reportedOIE Handistatus, 2005
BelgiumLast reported1897OIE Handistatus, 2005
Bosnia-HercegovinaDisease never reportedOIE Handistatus, 2005
BulgariaDisease never reportedOIE Handistatus, 2005
CroatiaDisease never reportedOIE Handistatus, 2005
CyprusDisease never reportedOIE Handistatus, 2005
Czech RepublicLast reported1902OIE Handistatus, 2005
DenmarkLast reported1886OIE Handistatus, 2005
EstoniaDisease never reportedOIE Handistatus, 2005
FinlandLast reported1920OIE Handistatus, 2005
FranceLast reported1984OIE Handistatus, 2005
GermanyLast reported1926OIE Handistatus, 2005
GreeceDisease never reportedOIE Handistatus, 2005
HungaryLast reported1901OIE Handistatus, 2005
IcelandDisease never reportedOIE Handistatus, 2005
IrelandLast reported1892OIE Handistatus, 2005
Isle of Man (UK)Disease never reportedOIE Handistatus, 2005
ItalyLast reported1993OIE Handistatus, 2005
JerseyDisease never reportedOIE Handistatus, 2005
LatviaLast reported1922OIE Handistatus, 2005
LiechtensteinDisease not reportedOIE Handistatus, 2005
LithuaniaDisease never reportedOIE Handistatus, 2005
LuxembourgDisease never reportedOIE Handistatus, 2005
MacedoniaDisease never reportedOIE Handistatus, 2005
MaltaDisease never reportedOIE Handistatus, 2005
MoldovaLast reported1946OIE Handistatus, 2005
NetherlandsLast reported1887OIE Handistatus, 2005
NorwayLast reported1860OIE Handistatus, 2005
PolandLast reported1936OIE Handistatus, 2005
PortugalLast reported1999OIE Handistatus, 2005
RomaniaLast reported1919OIE Handistatus, 2005
Russian FederationLast reported1928OIE Handistatus, 2005
SlovakiaLast reported1902OIE Handistatus, 2005
SloveniaDisease never reportedOIE Handistatus, 2005
SpainLast reported1994OIE Handistatus, 2005
SwedenLast reported1856OIE Handistatus, 2005
SwitzerlandLast reported1895OIE Handistatus, 2005
UKLast reported1898OIE Handistatus, 2005
-Northern IrelandLast reported1893OIE Handistatus, 2005
UkraineDisease never reportedOIE Handistatus, 2005
Yugoslavia (former)Disease never reportedOIE Handistatus, 2005
Yugoslavia (Serbia and Montenegro)Disease never reportedOIE Handistatus, 2005

Oceania

AustraliaLast reported1967OIE Handistatus, 2005
French PolynesiaDisease never reportedOIE Handistatus, 2005
New CaledoniaDisease never reportedOIE Handistatus, 2005
New ZealandLast reported1864OIE Handistatus, 2005
SamoaDisease never reportedOIE Handistatus, 2005
VanuatuDisease never reportedOIE Handistatus, 2005
Wallis and Futuna IslandsNo information availableOIE Handistatus, 2005

Pathogen Characteristics

Top of page

Like all members of the Class Mollicutes, M. m. mycoides SC is small, simple and self-replicating, and distinguishable from walled bacteria because of a number of unique properties. The mollicutes lack a cell wall and the genetic machinery to synthesise one; they have low guanine/cytosine contents (less than 30%); they have small genomes and consequently small numbers of synthesised proteins. Attempts to measure the genome of M. m. mycoides SC strains have given disparate results depending on the technique used. Early work, using DNA thermal renaturation kinetics, estimated the size of the PG1 prototype strain as 760 kbp (Askaa et al., 1973) and 810 or 923 kbp (Razin et al., 1983). However, Pyle et al. (1990) gave a genome size value of 1280 kbp for this strain using the more reproducible pulse field gel electrophoresis (PFGE) technique.

Attempts to clarify the taxonomic position of the subspecies of M. mycoides have proved difficult. Results from DNA hybridisation studies, using single type strains, revealed a relatedness value (based on percentage homology) of 0.82 between M. m. mycoides SC and LC and 0.7 between M. m. mycoides SC and M. m. capri (Askaa et al., 1978). However, large differences in percentage hybridizations were seen in experiments between M. m. mycoides SC and M. m. capri depending which genomic DNA was tritium labelled. Protein studies gave a slightly different picture. Costas et al. (1987) examined cellular proteins of 26 isolates belonging to the cluster by SDS-PAGE and showed protein patterns to be generally similar with many shared bands. However, numerical analysis of the patterns and using a correlation coefficient revealed four distinct groups or phenons at a similarity level of 70%:

M. m. mycoides SC strains

M. m. mycoides LC and M. m. capri

M. capricolum and F38

BG7

A very close relationship between M. m. mycoides LC and M. m. capri was revealed as there were difficulties in distinguishing isolates from each subspecies even at the 75% level. More extensive studies confirmed the inseparability of M. m. mycoides LC and M. m. capri using protein analysis but showed that in most cases serological tests, in particular immunofluorescence, could distinguish the subspecies designations (Leach et al., 1989). Interestingly, several strains were serologically intermediate between the two subspecies being cross reactive with both.

Early attempts to classify the mollicutes using immunological and molecular biological approaches provided useful taxonomic data but provided no evolutionary information. More recent attempts at establishing phylogenetic relationships have concentrated on the highly conserved mycoplasmal ribosomal (r) RNA which, because of very tight structural constraints, has changed much less than the bulk of the genome. Complete sequences are known for some 450 bacteria. Weisburg et al. (1989) determined the small subunit (16S) rRNA sequences of over 40 species of mollicutes and specific walled bacteria. These workers confirmed the view that the initial event in mollicute phylogeny was the formation of the Acholeplasma branch from clostridial ancestors and later to ancestors of spiroplasmas probably without reductions in genome size. By repeated independent genomic reductions, the Spiroplasma branch led to Mycoplasma and Ureaplasma species. Systematic sequence analysis revealed that M. m. mycoides belonged to the spiroplasma group, one of the five groups of mollicutes. M. capricolum subspecies capricolum was also a member of this group which largely consisted of Spiroplasma spp. No other members of the M. mycoides group were analysed. The authors concluded that while phenotypically very different from bacteria, the mollicutes appear normal at the molecular level.

Over one hundred years since the cause of CBPP was discovered it is still not possible to say with certainty how M. m. mycoides SC causes disease. The elucidation of factors playing key roles in the pathogenicity of M. m. mycoides SC is hindered by the high cost of experimental infection studies using cattle and the absence of any small animal model in which disease is reproduced. Nevertheless, experimental infections have shown virulence differences amongst African strains (Provost et al., 1987) and morbidity and mortality are lower in European than in African disease outbreaks (Nicholas et al., 1996). The production of prolonged mycoplasmaemia after inoculation in mice has been used as an indication of differing virulence of some strains of M. m. mycoides SC (March and Brodie, 2000). The difficulty of reproducing disease symptoms in experimental infections using European M. m. mycoides SC strains (Abdo et al., 1998) may also indicate a reduced virulence compared to African strains. However, the pathological lesions caused during natural outbreaks in both Africa and Europe are identical and follow a similar pattern: during new outbreaks, many cattle show acute and sub-acute lesions while chronic lesions, sequestra predominate in later outbreaks. The striking difference is the almost complete lack of mortality and obvious morbidity seen in European outbreaks which must be due in part to improved husbandry and better health (Nicholas and Palmer, 1994).

The possible roles of the carbohydrate cell capsule and hydrogen peroxide production in M. m. mycoides SC infection were reviewed by Egwu et al. (1996). Capsules are generally considered to contribute to pathogenicity by promoting binding to host tissue surfaces and enhancing resistance to phagocytosis. In addition, there is some evidence that the capsule of M. m. mycoides SC might have a direct toxic effect on host cells and its structural similarity to bovine pneumogalactan further suggests that it might induce auto-immune reactions. Analysis of concentrated and partially purified capsular material from European M. m. mycoides SC strains are consistent with earlier work for the Australian strains V5 and Gladysdale (Plackett et al., 1963) which indicated that the major carbohydrate (>90%) is galactose. There was no evidence to indicate that the capsule was comprised of several sugars (N-acetylglucosamine, fructose, fucose, glucosamine, glucose and mannose) in approximately equal proportions, as recently suggested by March et al. (1999a; 1999b).

The production of hydrogen peroxide and other active oxygen species appears to be an important factor in mycoplasma pathogenicity (Tryon and Baseman, 1992). In mycoplasmas, hydrogen peroxide production may accompany the metabolism of sugars or certain organic acids to acetate plus carbon dioxide. However, in M. mycoides, only traces of hydrogen peroxide are formed (Miles et al., 1991).

Disease(s) associated with this pathogen is/are on the list of diseases notifiable to the World Organisation for Animal Health (OIE). The distribution section contains data from OIE's Handistatus database on disease occurrence. Please see the AHPC library for further information from OIE, including the International Animal Health Code and the Manual of Standards for Diagnostic Tests and Vaccines. Also see the website: www.oie.int.

Host Animals

Top of page
Animal nameContextLife stageSystem
Bos bison (American bison)Domesticated host
Bos grunniens (yaks)Domesticated host
Bos indicus (zebu)Domesticated host
Bos mutus (yaks, wild)Domesticated host
Bos taurus (cattle)Domesticated host
Bubalus bubalis (Asian water buffalo)Domesticated host
Capra hircus (goats)Domesticated host
Ovis aries (sheep)Domesticated host

References

Top of page

Abdo EM; Nicolet J; Miserez R; GonÇalves R; Regalla J; Griot C; Bensaide A; Krampe M; Frey J, 1998. Humoral and bronchial immune responses in cattle experimentally infected with Mycoplasma mycoides subsp. mycoides small colony type. Veterinary Microbiology, 59(2/3):109-122; 29 ref.

Askaa G; Christiansen C; Erno H, 1973. Bovine mycoplasmas: genome size and base composition of DNA. Journal of General Microbiology, 75:283-286.

Askaa G; Erno H; Ojo MO, 1978. Bovine mycoplasmas: Classification of groups related to Mycoplasma mycoides. Acta Veterinaria Scandinavia, 19:166-178.

Costas M; Leach RH; Mitchelmore DL, 1987. Numerical analysis of PAGE protein patterns and the taxonomic relationships within the 'Mycoplasma mycoides cluster'. Journal of General Microbiology, 133(12):3319-3329; 16 ref.

Egwu GE; Nicholas RAJ; Ameh JA; Bashiruddin JB, 1996. Contagious bovine pleuropneumonia: an update. Veterinary Bulletin, 66:875-888.

Freundt EA, 1955. The classification of the pleuropneumonia-like group of organisms (Borrelomycetales). International Bulletin of Bacteriological Nomenclature and Taxonomy, 5:67-78.

Leach RH; Costas M; Mitchelmore DL, 1989. Relationship between Mycoplasma mycoides subsp. mycoides ('Large-colony' strains) and M. mycoides subsp. capri, as indicated by numerical analysis of one-dimensional SDS-PAGE protein patterns. Journal of General Microbiology, 135(11):2993-3000; 17 ref.

March JB. Jones GE, Williamson HS, Amanfu W, 1999b. Studies on the immunological diversity of type, vaccine and wild strains of Mycoplasma mycoides subsp. mycoides SC. In: Stipkovits L, Rosengarten R, Frey J, eds. Mycoplasmas of ruminants: pathogenicity, diagnostics, epidemiology and molecular genetics. Volume III. Luxembourg, Germany: Office for official publications of the European Communities, 159-162.

March JB; Brodie M, 2000. Comparison of the virulence of European and African isolates of Mycoplasma mycoides subspecies mycoides small colony type. Veterinary Record, 147:20-21.

March JB; Hitchen P; Morris HR; Dell A, 1999a. Analysis of the capsular polysaccharide of Mycoplasma mycoides subsp. mycoides SC, the causal agent of CBPP: purification, composition and its role in infection and immunity. In: Stipkovits L, Rosengarten R, Frey J, eds. Mycoplasmas of ruminants: pathogenicity, diagnostics, epidemiology and molecular genetics. Volume III. Luxembourg, Grmany: Office for official publications of the European Communities, 69-72.

Miles RJ; Taylor RR; Varsani H, 1991. Oxygen uptake and H2O2 production by fermentative Mycoplasma spp. Journal of Medical Microbiology, 34:219-223.

Nicholas RAJ; Palmer NMA, 1994. Contagious bovine pleuropneumonia in Europe. State Veterinary Journal, 4:14-16.

Nicholas RAJ; Santini FG; Clark KM; Palmer NMA; Santis Pde; Bashiruddin JB, 1996. A comparison of serological tests and gross lung pathology for detecting contagious bovine pleuropneumonia in two groups of Italian cattle. Veterinary Record, 139(4):89-93; 16 ref.

OIE Handistatus, 2002. World Animal Health Publication and Handistatus II (dataset for 2001). Paris, France: Office International des Epizooties.

OIE Handistatus, 2003. World Animal Health Publication and Handistatus II (dataset for 2002). Paris, France: Office International des Epizooties.

OIE Handistatus, 2004. World Animal Health Publication and Handistatus II (data set for 2003). Paris, France: Office International des Epizooties.

OIE Handistatus, 2005. World Animal Health Publication and Handistatus II (data set for 2004). Paris, France: Office International des Epizooties.

Plackett P; Buttery SH; Cottew GS, 1963. Carbohydrates of some mycoplasma strains. Proceedings of the 8th International Congress for Microbiology, Montreal, 1962. Recent Progress in Microbiology, 8:535-547.

Provost A; Perreau P; Bréard A; Goff Cle; Martel JL; Cottew GS, 1987. Contagious bovine pleuropneumonia. Revue Scientifique et Technique, Office International des épizooties, 6(3):565-679; 99 ref.

Pyle LE; Taylor T; Finch LR, 1990. Genomic maps of some strains within the Mycoplasma mycoides cluster. Journal of Bacteriology, 172(12):7265-7268; 20 ref.

Razin S; Barile MF; Harasawa R; Amikam D; Glaser DG, 1983. Characterisation of the mycoplasma genome. Yale Journal of Biological Medicine, 56:357-366.

Tryon VV; Baseman JB, 1992. Pathogenic mechanisms and determinants. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. Mycoplasmas: molecular biology and pathogenesis. Washington DC, USA: American Society for Microbiology, 457-471.

Weisburg WG; Tully JG; Rose DL; Petzel JP; Oyaizu H; Yang D; Mandelco L; Sechrest J; Lawrence TG; Etten Jvan; Maniloff J; Woese CR, 1989. A phylogenetic analysis of the mycoplasmas: basis for their classification. Journal of Bacteriology, 171(12):6455-6467; 50 ref.

Distribution Maps

Top of page
You can pan and zoom the map
Save map